Erik W Thompson

ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 38

Top Venues

Cancers

Pharmaceutics

Biomolecules

Clinical & experimental metastasis

Queensland University of Technology

Griffith University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Queensland University of Technology

Australia

Professor of Breast Cancer Research :: Institute of Health and Biomedical Innovation

Education History

Griffith University

Australia

PHD

Publications

Satcha Foongkajornkiat, Kamil Sokolowski, James Stephenson, Thomas Lloyd, Honor J Hugo, Erik W Thompson, Konstantin I Momot
Quantitative measurement of mammographic density in breast-tissue explants using portable NMR: Precision and accuracy. Magnetic resonance in medicine (2024)
Satcha Foongkajornkiat, Kamil Sokolowski, James Stephenson, Thomas Lloyd, Honor J Hugo, Erik W Thompson, Konstantin I Momot
Quantitative measurement of mammographic density in breast-tissue explants using portable NMR: Precision and accuracy. Magnetic resonance in medicine 92 (1) (2024)
Nathalie Bock, Farzaneh Forouz, Luke Hipwood, Julien Clegg, Penny Jeffery, Madeline Gough, Tirsa van Wyngaard, Christopher Pyke, Mark Nathaniel Adams, Laura J Bray, Laura Croft, Erik W Thompson, Thomas Kryza, Christoph Meinert
GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids. Pharmaceutics 15 (1) (2023)
Nathalie Bock, Farzaneh Forouz, Luke Hipwood, Julien Clegg, Penny Jeffery, Madeline Gough, Tirsa van Wyngaard, Christopher Pyke, Mark Nathaniel Adams, Laura J Bray, Laura Croft, Erik W Thompson, Thomas Kryza, Christoph Meinert
GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids. Pharmaceutics 15 (1) (2023)
Nathalie Bock, Farzaneh Forouz, Luke Hipwood, Julien Clegg, Penny Jeffery, Madeline Gough, Tirsa van Wyngaard, Christopher Pyke, Mark Nathaniel Adams, Laura J Bray, Laura Croft, Erik W Thompson, Thomas Kryza, Christoph Meinert
GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids. Pharmaceutics 15 (1) (2023)
Jinyong Lin, Dong Li, Changhong Li, Ziqi Zhuang, Chengchao Chu, Kostya Ken Ostrikov, Erik W Thompson, Gang Liu, Peiyu Wang
A review on reactive oxygen species (ROS)-inducing nanoparticles activated by uni- or multi-modal dynamic treatment for oncotherapy. Nanoscale (2023)
Nathalie Bock, Farzaneh Forouz, Luke Hipwood, Julien Clegg, Penny Jeffery, Madeline Gough, Tirsa van Wyngaard, Christopher Pyke, Mark Nathaniel Adams, Laura J Bray, Laura Croft, Erik W Thompson, Thomas Kryza, Christoph Meinert
GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids. Pharmaceutics 15 (1) (2023)
Charlene Waryah, Eric Alves, Roberta Mazzieri, Riccardo Dolcetti, Erik W Thompson, Andrew D Redfern, Pilar Blancafort
Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs. Cancers 15 (12) (2023)
Nathalie Bock, Farzaneh Forouz, Luke Hipwood, Julien Clegg, Penny Jeffery, Madeline Gough, Tirsa van Wyngaard, Christopher Pyke, Mark Nathaniel Adams, Laura J Bray, Laura Croft, Erik W Thompson, Thomas Kryza, Christoph Meinert
GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids. Pharmaceutics 15 (1) (2023)
Xiaofeng Dai, Erik W Thompson, Kostya Ken Ostrikov
Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers. Biomolecules 12 (12) (2022)
Xiaofeng Dai, Erik W Thompson, Kostya Ken Ostrikov
Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers. Biomolecules 12 (12) (2022)
Xiaofeng Dai, Erik W Thompson, Kostya Ken Ostrikov
Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers. Biomolecules 12 (12) (2022)
Meilan Hu, Fule He, Erik W Thompson, Kostya Ken Ostrikov, Xiaofeng Dai
Lysine Acetylation, Cancer Hallmarks and Emerging Onco-Therapeutic Opportunities. Cancers 14 (2) (2022)
Paras Jain, Sugandha Bhatia, Erik W Thompson, Mohit Kumar Jolly
Population Dynamics of Epithelial-Mesenchymal Heterogeneity in Cancer Cells. Biomolecules 12 (3) (2022)
Xiaofeng Dai, Erik W Thompson, Kostya Ken Ostrikov
Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers. Biomolecules 12 (12) (2022)
Ryan J Murphy, Pascal R Buenzli, Tamara A Tambyah, Erik W Thompson, Honor J Hugo, Ruth E Baker, Matthew J Simpson
The role of mechanical interactions in EMT. Physical biology 18 (4) (2021)
Peiyu Wang, Renwu Zhou, Patrick B Thomas, Liqian Zhao, Rusen Zhou, Susmita Mandal, Mohit Kumar Jolly, Derek J Richard, Bernd H A Rehm, Kostya Ken Ostrikov, Xiaofeng Dai, Elizabeth D Williams, Erik W Thompson
Epithelial-to-Mesenchymal Transition Enhances Cancer Cell Sensitivity to Cytotoxic Effects of Cold Atmospheric Plasmas in Breast and Bladder Cancer Systems. Cancers 13 (12) (2021)
Lucas J Wager, Dominic Guanzon, David Ian Leavesley, Erik W Thompson, Rachael Zoe Murray
Partial Epithelial-Mesenchymal Transition: Reduced miR-4792 and miR-146b-5p Inversely Correlated with SIAH2 in Migrating Keratinocytes in Vitro. Experimental dermatology 30 (12) (2021)
Gina Reye, Xuan Huang, Kara L Britt, Christoph Meinert, Tony Blick, Yannan Xu, Konstantin I Momot, Thomas Lloyd, Jason J Northey, Erik W Thompson, Honor J Hugo
RASSF1A Suppression as a Potential Regulator of Mechano-Pathobiology Associated with Mammographic Density in BRCA Mutation Carriers. Cancers 13 (13) (2021)
Sara Hassan, Tony Blick, Erik W Thompson, Elizabeth D Williams
Diversity of Epithelial-Mesenchymal Phenotypes in Circulating Tumour Cells from Prostate Cancer Patient-Derived Xenograft Models. Cancers 13 (11) (2021)
Jing Yang, Parker Antin, Geert Berx, Cédric Blanpain, Thomas Brabletz, Marianne Bronner, Kyra Campbell, Amparo Cano, Jordi Casanova, Gerhard Christofori, Shoukat Dedhar, Rik Derynck, Heide L Ford, Jonas Fuxe, Antonio García de Herreros, Gregory J Goodall, Anna-Katerina Hadjantonakis, Ruby Y J Huang, Chaya Kalcheim, Raghu Kalluri, Yibin Kang, Yeesim Khew-Goodall, Herbert Levine, Jinsong Liu, Gregory D Longmore, Sendurai A Mani, Joan Massagué, Roberto Mayor, David McClay, Keith E Mostov, Donald F Newgreen, M Angela Nieto, Alain Puisieux, Raymond B Runyan, Pierre Savagner, Ben Stanger, Marc P Stemmler, Yoshiko Takahashi, Masatoshi Takeichi, Eric Théveneau, Jean-Paul Thiery, Erik W Thompson, Robert A Weinberg, Elizabeth D Williams, Jianhua Xing, Binhua P Zhou, Guojun Sheng, null null
Guidelines and definitions for research on epithelial-mesenchymal transition. Nature reviews. Molecular cell biology 21 (6) (2020)
Xiaofeng Dai, Kateryna Bazaka, Erik W Thompson, Kostya Ken Ostrikov
Cold Atmospheric Plasma: A Promising Controller of Cancer Cell States. Cancers 12 (11) (2020)
Iman Azimi, Mélanie Robitaille, Kaela Armitage, Choon Leng So, Michael J G Milevskiy, Korinne Northwood, Huai Fang Lim, Erik W Thompson, Sarah J Roberts-Thomson, Gregory R Monteith
Activation of the Ion Channel TRPV4 Induces Epithelial to Mesenchymal Transition in Breast Cancer Cells. International journal of molecular sciences 21 (24) (2020)
Sugandha Bhatia, Tony Blick, Cletus Pinto, Mark Waltham, James H Monkman, Ekaterina Ivanova, Pamela M Pollock, Shivashankar H Nagaraj, Adrian P Wiegmans, Izhak Haviv, Kaylene J Simpson, Erik W Thompson
Identifying Therapies to Combat Epithelial Mesenchymal Plasticity-Associated Chemoresistance to Conventional Breast Cancer Therapies Using An shRNA Library Screen. Cancers 12 (5) (2020)
Michael S Shawky, Cecilia W Huo, Michael A Henderson, Andrew Redfern, Kara Britt, Erik W Thompson
A review of the influence of mammographic density on breast cancer clinical and pathological phenotype. Breast cancer research and treatment 177 (2) (2019)
Elizabeth D Williams, Dingcheng Gao, Andrew Redfern, Erik W Thompson
Controversies around epithelial-mesenchymal plasticity in cancer metastasis. Nature reviews. Cancer 19 (12) (2019)
James H Monkman, Erik W Thompson, Shivashankar H Nagaraj
Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous Disease. Cancers 11 (11) (2019)
Iman Azimi, Michael J G Milevskiy, Silke B Chalmers, Kunsala T D S Yapa, Mélanie Robitaille, Christopher Henry, Gregory J Baillie, Erik W Thompson, Sarah J Roberts-Thomson, Gregory R Monteith
ORAI1 and ORAI3 in Breast Cancer Molecular Subtypes and the Identification of ORAI3 as a Hypoxia Sensitive Gene and a Regulator of Hypoxia Responses. Cancers 11 (2) (2019)
Renwu Zhou, Peiyu Wang, Yanru Guo, Xiaofeng Dai, Shaoqing Xiao, Zhi Fang, Robert Speight, Erik W Thompson, Patrick J Cullen, Kostya Ken Ostrikov
Prussian blue analogue nanoenzymes mitigate oxidative stress and boost bio-fermentation. Nanoscale 11 (41) (2019)
Ajay Balakrishnan, Deepak Koppaka, Abhishek Anand, Barnali Deb, Gianluca Grenci, Virgile Viasnoff, Erik W Thompson, Harsha Gowda, Ramray Bhat, Annapoorni Rangarajan, Jean-Paul Thiery, K Govind Babu, Prashant Kumar
Circulating Tumor Cell cluster phenotype allows monitoring response to treatment and predicts survival. Scientific reports 9 (1) (2019)
Sugandha Bhatia, James Monkman, Tony Blick, Pascal H G Duijf, Shivashankar H Nagaraj, Erik W Thompson
Multi-Omics Characterization of the Spontaneous Mesenchymal-Epithelial Transition in the PMC42 Breast Cancer Cell Lines. Journal of clinical medicine 8 (8) (2019)
Anthony Tachtsidis, Anh Viet-Phuong Le, Tony Blick, Devika Gunasinghe, Emma De Sousa, Mark Waltham, Alex Dobrovic, Erik W Thompson
Human-specific RNA analysis shows uncoupled epithelial-mesenchymal plasticity in circulating and disseminated tumour cells from human breast cancer xenografts. Clinical & experimental metastasis 36 (4) (2019)
Teneale A Stewart, Iman Azimi, Daneth Marcial, Amelia A Peters, Silke B Chalmers, Kunsala T D S Yapa, Erik W Thompson, Sarah J Roberts-Thomson, Gregory R Monteith
Differential engagement of ORAI1 and TRPC1 in the induction of vimentin expression by different stimuli. Laboratory investigation; a journal of technical methods and pathology 100 (2) (2019)
Anna Chen, Jaclyn Sceneay, Nathan Gödde, Tanja Kinwel, Sunyoung Ham, Erik W Thompson, Patrick O Humbert, Andreas Möller
Intermittent hypoxia induces a metastatic phenotype in breast cancer. Oncogene 37 (31) (2018)
Andrew D Redfern, Lisa J Spalding, Erik W Thompson
The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome. Clinical & experimental metastasis 35 (4) (2018)
Lucas J Wager, Rachael Zoe Murray, Erik W Thompson, David Ian Leavesley
A fence barrier method of leading edge cell capture for explorative biochemical research. Cell adhesion & migration 11 (5-6) (2017)
Sandeep Satapathy, Jyotsna Batra, Varinder Jeet, Erik W Thompson, C Punyadeera
MicroRNAs in HPV associated cancers: small players with big consequences. Expert review of molecular diagnostics 17 (7) (2017)
Iman Azimi, Rosalie M Petersen, Erik W Thompson, Sarah J Roberts-Thomson, Gregory R Monteith
Hypoxia-induced reactive oxygen species mediate N-cadherin and SERPINE1 expression, EGFR signalling and motility in MDA-MB-468 breast cancer cells. Scientific reports 7 (1) (2017)

Erik W Thompson.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Erik W Thompson